Russell Investments Group, Ltd. Bio Atla, Inc. Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$1.37 - $3.92 $11,901 - $34,053	8,687 Added 4524.48%	8,879 $12,000
Q1 2024 May 08, 2024	BUY	$1.88 - $3.46 $360 - $664	192 New	192 $0
Q2 2022 Jul 29, 2022	BUY	$2.13 - $5.38 $19,809 - $50,034	9,300 Added 16.26%	66,500 $189,000
Q1 2022 May 05, 2022	BUY	$4.38 - $18.78 $250,536 - $1.07 Million	57,200 New	57,200 $286,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.